Literature DB >> 2437988

Muscarinic activity of McN-A-343 and its value in muscarinic receptor classification.

R M Eglen, B A Kenny, A D Michel, R L Whiting.   

Abstract

The affinity and potency of McN-A-343 (4-(m-chlorophenyl-carbamoyloxy) -2-butynyltrimethylammonium chloride) has been assessed at a range of M1 and M2 muscarinic receptors. McN-A-343 was shown to act as a full agonist at M2 receptors present in the guinea-pig isolated taenia caeci (-log EC50 = 5.14). McN-A-343 exhibited no agonist action in the guinea-pig ileum, atria, bladder or trachea. McN-A-343 was not selective in terms of affinity since its dissociation constants at M1 and M2 binding sites in the rat cerebral cortex and myocardium respectively, were very similar (cortical pPKi = 5.05; myocardial pKi = 5.22). The selectivity previously reported for the compound may be due to differences in intrinsic efficacy and/or tissue receptor reserve. Based on differential antagonist affinities, the muscarinic receptor profile of the taenia caeci, trachea and bladder was similar to that observed in the ileum, but dissimiliar to that observed in the atria.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2437988      PMCID: PMC1917196          DOI: 10.1111/j.1476-5381.1987.tb11222.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  24 in total

1.  Contraction of the urinary bladder by muscarinic ganglionic stimulants: possible existence of muscarinic receptor sites on its parasympathetic ganglia.

Authors:  P R Saxena
Journal:  Arch Int Pharmacodyn Ther       Date:  1972-09

2.  Negative chronotropic effects of McN A-343 and nicotine in isolated guinea-pig atria: insensitivity to blockade by tetrodotoxin.

Authors:  A J Pappano; R A Rembish
Journal:  J Pharmacol Exp Ther       Date:  1971-04       Impact factor: 4.030

3.  Antagonist discrimination between ganglionic and ileal muscarinic receptors.

Authors:  D A Brown; A Forward; S Marsh
Journal:  Br J Pharmacol       Date:  1980       Impact factor: 8.739

4.  Ligand: a versatile computerized approach for characterization of ligand-binding systems.

Authors:  P J Munson; D Rodbard
Journal:  Anal Biochem       Date:  1980-09-01       Impact factor: 3.365

5.  Muscarinic receptor subtypes: M1 and M2 biochemical and functional characterization.

Authors:  R Hammer; A Giachetti
Journal:  Life Sci       Date:  1982-12-27       Impact factor: 5.037

6.  Three types of muscarinic receptors? [proceedings].

Authors:  R B Barlow; K N Burston; A Vis
Journal:  Br J Pharmacol       Date:  1980-01       Impact factor: 8.739

7.  [3H]Rauwolscine and [3H]yohimbine binding to rat cerebral and human platelet membranes: possible heterogeneity of alpha 2-adrenoceptors.

Authors:  Y D Cheung; D B Barnett; S R Nahorski
Journal:  Eur J Pharmacol       Date:  1982-10-15       Impact factor: 4.432

8.  Muscarinic receptors in rat sympathetic ganglia.

Authors:  D A Brown; S Fatherazi; J Garthwaite; R D White
Journal:  Br J Pharmacol       Date:  1980-12       Impact factor: 8.739

9.  The actions of some cholinomimetic drugs on the isolated taenia of the guinea-pig caecum.

Authors:  F Hobbiger; F Mitchelson; M J Rand
Journal:  Br J Pharmacol       Date:  1969-05       Impact factor: 8.739

10.  Effects of McN-A-343 and DMPP on the uptake and release of 3 H-noradrenaline by guinea-pig atria.

Authors:  G S Allen; M J Rand; D F Story
Journal:  Br J Pharmacol       Date:  1972-07       Impact factor: 8.739

View more
  11 in total

1.  Characterization of the muscarine receptor type on paracrine cells activated by McN-A-343 in the mouse isolated stomach.

Authors:  W Kromer; E Baron; M Beinborn; R Boer; M Eltze
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1990-03       Impact factor: 3.000

2.  Antagonistic properties of McNeil-A-343 at 5-HT4 and 5-HT3 receptors.

Authors:  A Sagrada; G B Schiavi; E Cereda; H Ladinsky
Journal:  Br J Pharmacol       Date:  1994-11       Impact factor: 8.739

3.  Assessment of the muscarinic receptor subtype involved in the mediation of pilocarpine-induced purposeless chewing behaviour.

Authors:  B R Stewart; P Jenner; C D Marsden
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

4.  Stimulation by McN-A-343 and blockade by telenzepine of acid secretion in the mouse isolated stomach at histamine-liberating cells.

Authors:  W Kromer; E Baron; M Beinborn; M Eltze; W A Simon
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1989-07       Impact factor: 3.000

5.  Characterization of the muscarinic receptor subtype involved in phosphoinositide metabolism in bovine tracheal smooth muscle.

Authors:  A F Roffel; H Meurs; C R Elzinga; J Zaagsma
Journal:  Br J Pharmacol       Date:  1990-02       Impact factor: 8.739

6.  Heterogeneity of muscarinic receptors in lamb isolated coronary resistance arteries.

Authors:  U Simonsen; D Prieto; L Rivera; M Hernández; M J Mulvany; A García-Sacristán
Journal:  Br J Pharmacol       Date:  1993-08       Impact factor: 8.739

7.  Interaction of selective compounds with muscarinic receptors at dispersed intestinal smooth muscle cells.

Authors:  E Barocelli; M Chiavarini; V Ballabeni; F Bordi; M Impicciatore
Journal:  Br J Pharmacol       Date:  1993-02       Impact factor: 8.739

8.  Receptor signaling mechanisms underlying muscarinic agonist-evoked contraction in guinea-pig ileal longitudinal smooth muscle.

Authors:  T Unno; S-C Kwon; H Okamoto; Y Irie; Y Kato; H Matsuyama; S Komori
Journal:  Br J Pharmacol       Date:  2003-05       Impact factor: 8.739

9.  Quest for agonist and antagonist selectivity at muscarinic receptors in guinea-pig smooth muscles and cardiac atria.

Authors:  N A Dorofeeva; S A Shelkovnikov; L A Starshinova; A F Danilov; J Nedoma; S Tucek
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1992-10       Impact factor: 3.000

10.  Application of a model to explore interspecies differences in acetylcholine M-receptor-stimulated gastric acid secretion.

Authors:  N J Welsh; N P Shankley; J W Black
Journal:  Br J Pharmacol       Date:  1995-07       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.